Related references
Note: Only part of the references are listed.Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition
Judy Tellam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cytosol to lysosome transport of intracellular antigens during immune surveillance
Victoria L. Crotzer et al.
TRAFFIC (2008)
Rethinking peptide supply to MHC class I molecules
Laurence C. Eisenlohr et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes
Judy Tellam et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Translation efficiency of EBNA1 encoded by lymphocryptoviruses influences endogenous presentation of CD8+ T cell epitopes
Judy Tellam et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
A role for intercellular antigen transfer in the recognition of EBV-transformed B cell lines by EBV nuclear antigen-specific CD4+ T cells
Graham S. Taylor et al.
JOURNAL OF IMMUNOLOGY (2006)
Cross-priming utilizes antigen not available to the direct presentation pathway
Keri B. Donohue et al.
IMMUNOLOGY (2006)
The DRiP hypothesis decennial: support, controversy, refinement and extension
Jonathan W. Yewdell et al.
TRENDS IN IMMUNOLOGY (2006)
Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products
Shu-Bing Qian et al.
JOURNAL OF IMMUNOLOGY (2006)
Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy
Eric A. Reits et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Protein synthesis upon acute nutrient restriction relies on proteasome function
RM Vabulas et al.
SCIENCE (2005)
Quantifying the contribution of defective ribosomal products to antigen production:: A model-based computational analysis
S Bulik et al.
JOURNAL OF IMMUNOLOGY (2005)
Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens
DL Zhou et al.
IMMUNITY (2005)
CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines
HM Long et al.
JOURNAL OF VIROLOGY (2005)
Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro
A Chen et al.
JOURNAL OF VIROLOGY (2005)
Endogenous MHC class II processing of a viral nuclear antigen after autophagy
C Paludan et al.
SCIENCE (2005)
Stringent doxycycline-dependent control of gene activities using an episomal one-vector system
GW Bornkamm et al.
NUCLEIC ACIDS RESEARCH (2005)
Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes
KS Voo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
CD8 T cell recognition of endogenously expressed Epstein-Barr virus nuclear antigen 1
SP Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1
J Tellam et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1
Y Yin et al.
SCIENCE (2003)
Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy
F Nimmerjahn et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Quantitating protein synthesis, degradation, and endogenous antigen processing
MF Princiotta et al.
IMMUNITY (2003)
Latent gene sequencing reveals familial relationships among chinese Epstein-Barr virus strains and evidence for positive selection of all epitope changes
RS Midgley et al.
JOURNAL OF VIROLOGY (2003)
Cutting edge: Neosynthesis is required for the presentation of a T cell epitope from a long-lived viral protein
S Khan et al.
JOURNAL OF IMMUNOLOGY (2001)
Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4+ T-helper 1 responses
A Leen et al.
JOURNAL OF VIROLOGY (2001)
The major substrates for TAP in vivo are derived from newly synthesized proteins
EAJ Reits et al.
NATURE (2000)
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
U Schubert et al.
NATURE (2000)
Share Paper
